drug prices

Big Pharma’s Tariff Reckoning: Drug Stocks Brace for 100% Duties

September 12, 2026April 14, 2026 by Bruno M.

The Trump administration’s 100% pharmaceutical tariff threat is testing drug stock valuations, global supply chains, and corporate bond markets.

Search

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

Please leave this field empty

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.